Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.35 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.31 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15479026 | 0.87 | SMN1; SMN2 (0.37) | SMN1; SMN2CA14KMT2AMEN1KEAP1 | |
| SCHEMBL17242153 | 0.87 | SMN1; SMN2 (0.42) | SMN1; SMN2CA14KMT2AMEN1KEAP1 | |
| SCHEMBL25231160 | 0.85 | SMN1; SMN2 (0.36) | SMN1; SMN2CA14KMT2AMEN1TSHR | |
| SCHEMBL7041842 | 0.82 | SMN1; SMN2 (0.46) | SMN1; SMN2CA14KMT2AMEN1KEAP1 | |
| SCHEMBL5307279 | 0.82 | SMN1; SMN2 (0.33) | SMN1; SMN2KMT2AMEN1 | |
| SCHEMBL6724896 | 0.76 | — | — | |
| SCHEMBL30573445 | 0.76 | — | — | |
| SCHEMBL12907664 | 0.76 | — | — | |
| SCHEMBL615765 | 0.76 | — | — | |
| SCHEMBL2911301 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230216087-A1 | IN-SITU POLYMERIZED SOLID-STATE BATTERY WITH MULTILAYER ELECTROLYTE AND PREPARATION METHOD THEREOF | BEIJING WELION NEW ENERGY TECHNOLOGY CO., LTD (CN) | 2023-07-06 | — | — | US | claimed |
| EP-4207418-A2 | IN-SITU POLYMERIZED SOLID-STATE BATTERY WITH MULTILAYER STRUCTURAL ELECTROLYTE AND PREPARATION METHOD THEREOF | Beijing WeLion New Energy Technology Co., Ltd (CN) | 2023-07-05 | — | — | EP | claimed |
| US-20230216087-A1 | IN-SITU POLYMERIZED SOLID-STATE BATTERY WITH MULTILAYER ELECTROLYTE AND PREPARATION METHOD THEREOF | BEIJING WELION NEW ENERGY TECHNOLOGY CO., LTD (CN) | 2023-07-06 | — | — | US | disclosed |
| EP-4207418-A2 | IN-SITU POLYMERIZED SOLID-STATE BATTERY WITH MULTILAYER STRUCTURAL ELECTROLYTE AND PREPARATION METHOD THEREOF | Beijing WeLion New Energy Technology Co., Ltd (CN) | 2023-07-05 | — | — | EP | disclosed |
| CN-115548463-B | Semi-solid battery and preparation method thereof | 天能电池集团股份有限公司 | 2023-04-25 | — | — | CN | disclosed |
| CN-101675034-A | Pyridone derivatives as p38a mapk inhibitors | ASTELLAS PHARMA INC | 2010-03-17 | — | — | CN | disclosed |
| CN-101193888-A | Synthesis method of pyrroloquinoline quinone (PQQ) | CLF MEDICAL TECHNOLOGY ACCELERATION PROGRAM INC (US) | 2008-06-04 | — | — | CN | disclosed |
| EP-1631645-A1 | FUEL COMPOUND EXHIBITING IMPROVED COLD FLOW PROPERTIES | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-08 | — | — | EP | disclosed |
| WO-2004106470-A1 | FUEL COMPOUND EXHIBITING IMPROVED COLD FLOW PROPERTIES | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-09 | — | — | WO | disclosed |